TABLE 2.
C. auris surveillance assay cartridge (CaurisSurV cartridge) performance against the sample sets from two different sitese
| Culture positives PCRa positives | Culture negatives PCR positives | Combined PCR Positivesb | PCR negativesc | |||||
|---|---|---|---|---|---|---|---|---|
| UCLA (N = 31) | WW (N = 10) | UCLA (N = 10) | WW | UCLA + WW (N = 51) | UCLA (N = 31) | WW (N = 3) | ||
| CaurisSurV Cartridge | Positives | 30 | 10 | 6 | 0 | 46 | 0 | 0 |
| Negatives | 1 | 0 | 3 | 0 | 4 | 29 | 3 | |
| Invalidsd | 0 | 0 | 1 | 0 | 1 | 2 | 0 | |
| Sensitivity (%) | 96.8 | 100.0 | 66.7 | NA | NA | |||
| Combined sensitivity (%) | 97.5 | 92 | ||||||
| Specificity (%) | 100.0 | 100.0 | ||||||
a
BDMax PCR assay.
b
Irrespective of culture positivity.
c
Culture not done.
d
Invalids were excluded from sensitivity/specificity calculations.
e
WW, Wadsworth Center, NY; NA, not applicable.